Mapping the Evidence and Regulatory Landscape for High-Risk and Innovative Medical Devices and IVDs
The EU4MEDTECH consortium has completed WP1, which provided an extensive analysis of the current European landscape related to the generation, evaluation, and integration of clinical and performance evidence for high-risk and innovative medical devices (MDs) and in vitro diagnostic devices (IVDs).
The overarching objective of WP1 was to develop a comprehensive understanding of how different types of evidence are generated and assessed across the device lifecycle, and how these processes support regulatory compliance, patient safety, and innovation.
Mapping methodologies and evidence sources
WP1 involved a systematic review of scientific literature, policy and guidance documents, and other grey sources to map existing methodologies and practices for clinical and performance evidence generation. This included a particular focus on the role of real-world data, registries, and post-market data in supporting regulatory submissions and continuous device evaluation.
The analysis also explored emerging approaches to integrating diverse evidence sources, to support robust and efficient assessments of device safety and performance.
Understanding the regulatory environment
In parallel, WP1 reviewed the existing common specifications (CS), standards, and overlapping regulatory frameworks that apply to high-risk and innovative MDs and IVDs across Europe and internationally. This work provided a clear picture of the current regulatory landscape, highlighting the pathways, standards, and data requirements that manufacturers must navigate when seeking conformity under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).
Exploring digital solutions and market impacts
WP1 also examined the landscape of digital tools and software solutions currently used to support regulatory compliance in the MedTech industry. By identifying the strengths and limitations of these tools, the consortium was able to outline gaps and opportunities for improvement, which will inform the design of the project’s own digital platform in later work packages.
Finally, WP1 assessed the economic and operational implications of MDR and IVDR implementation across EU Member States. Building on prior studies and stakeholder input, this activity helped to capture the diversity of experiences among manufacturers, including factors such as certification timelines, costs, and interactions with Notified Bodies.
Next steps
The outcomes of WP1 establish a strong evidence base for the next phases of the EU4MEDTECH project. The knowledge generated will directly support the development of a harmonised EU4MEDTECH framework and the digital platform. Through this work, EU4MEDTECH contributes to a more coherent, evidence-based, and innovation-friendly regulatory ecosystem in Europe.
Deliverables from WP1:
D1.1 Knowledge maps for evidence generation and integration
The EU4MEDTECH team developed knowledge maps that capture current and emerging approaches to generating and evaluating evidence for high-risk and innovative MDs and IVDs.
This work brings together insights from across Europe on how methodologies evolve to meet modern regulatory needs, forming a reference point for improving evidence generation and integration across the MedTech sector.
D1.2 Standards and common specifications (Sensitive)
EU4MEDTECH advanced its understanding of how standards and common specifications shape the regulatory landscape for high-risk and innovative MDs and IVDs.
A recently completed internal report reviewed current frameworks and standardisation efforts across Europe.
D1.3 Digital tools and MDR/IVDR impact assessment (Sensitive)
Digitalisation is transforming regulatory practice in the MedTech sector.
EU4MEDTECH conducted an internal analysis of existing digital tools and solutions supporting MDR and IVDR compliance and assessment.
The findings, shared among project partners, will inform the design of the forthcoming EU4MEDTECH digital platform.
D1.4 State-of-the-art methodologies for 3 use cases
The EU4MEDTECH consortium identified state-of-the-art methodologies applicable to the project’s three use cases.
This work outlines best practices for evidence generation and evaluation in different contexts, ensuring that future activities are based on a robust methodological foundation.
It strengthens the groundwork for developing practical, innovative solutions in the next phases of EU4MEDTECH.
